Pathnova@LKC rises to the challenge of increased Covid-19 cases
26 September 2021
Jessie Lim wrote a great article in the Straits Times on how Pathnova@LKC has been adapting to increased Covid-19 RT-qPCR testing since 1 Mar 2021. A few of our lab members were interviewed as representatives of our larger team.
From left to right: Mr. Jason Foo (COO), A/Prof Ian Cheong (CSO), Dr. Brian Wang (Team Leader), Melvin Ng (Systems Design Engineer), A/Prof Eric Yap (Medical Director).
(Photo credit: Liu ShuQi, Temasek Life Sciences Accelerator)
Also check out the cool video footage of our lab below.
Pathnova Laboratories, in partnership with NTU, is now operating a clinical diagnostic lab at the LKC School of Medicine
1 July 2021
Read about how Pathnova and NTU have teamed up since 1 March 2021 to support the national covid testing effort and to pursue innovations in clinical diagnostics.
A quick shout out to Temasek Life Sciences Accelerator for all their support.
From Right to Left: A/Prof Eric Yap, Mr. Jason Foo, E/Prof Chan Soh Ha, Dr. Ian Cheong. (Photo credit: Nanyang Technological University)
Temasek Trust write up
13 Nov 2017
Check out a write up on Pathnova in the Temasek Trust Newsletter (4th Quarter 2017). We are proud to provide the most predictive NPC detection assay in Singapore.
(Photo credit: Temasek Trust Newsletter)
The Next Chapter in IFA EBV serology
20 Oct 2017
A message to colleagues by Emeritus Professor Chan Soh Ha
The WHO Immunology Centre has provided IFA EBV serology services for Singapore and the region since the 80’s. One key service we offered was the detection of EBV activation through raised IgA antibodies to EBV Early Antigen (EA). This service was stopped about three years ago due to manpower issues.
I am now pleased to inform you that I have restarted the service under Pathnova Laboratories and will be working closely with researchers at Temasek Lifesciences Laboratory to develop pattern recognition technology to ensure continued service.
The ebv-EArly™ test offered by Pathnova Laboratories is the very same EBV IFA IgA anti-EA test previously offered by the WHO Immunology Centre with me performing the IFA. Additionally, our recently published results are promising and show that pattern recognition can improve IFA consistency. We will include this improved analysis at a later date for no extra charge.
All rights reserved. Contents © 2017 Pathnova Laboratories Pte Ltd
License No. 17I0288/01/172 (Private Hospitals and Medical Clinics Act, Chapter 248)
Disclaimer : The information contained in this website is provided for informational purposes only, and should not be construed as medical advice on any matter. Please contact us for specific queries.